Bayer Rises, Barclays Up, Campari Gains

On this episode of Stock Movers:

- The Trump administration urged the US Supreme Court to take up Bayer’s appeal targeting thousands of lawsuits blaming its top-selling Roundup weedkiller for causing cancer.
- The Bank of England cut its estimate of how much capital British banks need for the first time in a decade and signaled a consultation that could free up extra lending and higher payouts to shareholders, even as it flagged rising risks in private markets.
- Campari shares gain as much as 4.2% after Barclays raised its recommendation on the Italian spirits company, citing growth prospects in the US.

See omnystudio.com/listener for privacy information.